Literature DB >> 19135914

Host defense and pathogenesis in Staphylococcus aureus infections.

Frank R DeLeo1, Binh An Diep, Michael Otto.   

Abstract

Staphylococcus aureus is the most abundant cause of bacterial infections in the United States. As such, the pathogen has devised means to circumvent destruction by the innate immune system. Neutrophils are a critical component of innate immunity and the primary cellular defense against S aureus infections. This article reviews human neutrophil function in the context of S aureus virulence mechanisms and provides an overview of community-associated methicillin-resistant S aureus pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19135914      PMCID: PMC2748223          DOI: 10.1016/j.idc.2008.10.003

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  97 in total

Review 1.  Immune evasion by staphylococci.

Authors:  Timothy J Foster
Journal:  Nat Rev Microbiol       Date:  2005-12       Impact factor: 60.633

2.  Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia.

Authors:  Juliane Bubeck Wardenburg; Taeok Bae; Michael Otto; Frank R Deleo; Olaf Schneewind
Journal:  Nat Med       Date:  2007-12       Impact factor: 53.440

3.  Neutrophil chloramines: missing links between innate and acquired immunity.

Authors:  J Marcinkiewicz
Journal:  Immunol Today       Date:  1997-12

4.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

Review 5.  Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci.

Authors:  J J Langone
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

6.  A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation.

Authors:  A Coxon; P Rieu; F J Barkalow; S Askari; A H Sharpe; U H von Andrian; M A Arnaout; T N Mayadas
Journal:  Immunity       Date:  1996-12       Impact factor: 31.745

7.  Survival of Staphylococcus aureus inside neutrophils contributes to infection.

Authors:  H D Gresham; J H Lowrance; T E Caver; B S Wilson; A L Cheung; F P Lindberg
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

8.  The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus.

Authors:  Binh An Diep; Gregory G Stone; Li Basuino; Christopher J Graber; Alita Miller; Shelley-Ann des Etages; Alison Jones; Amy M Palazzolo-Ballance; Françoise Perdreau-Remington; George F Sensabaugh; Frank R DeLeo; Henry F Chambers
Journal:  J Infect Dis       Date:  2008-06-01       Impact factor: 5.226

9.  Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin.

Authors:  Binh An Diep; George F Sensabaugh; Naraporn Somboonna; Naraporn S Somboona; Heather A Carleton; Françoise Perdreau-Remington
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

10.  Defensins. Natural peptide antibiotics of human neutrophils.

Authors:  T Ganz; M E Selsted; D Szklarek; S S Harwig; K Daher; D F Bainton; R I Lehrer
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

View more
  93 in total

Review 1.  Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity.

Authors:  James E Cassat; Eric P Skaar
Journal:  Semin Immunopathol       Date:  2011-11-03       Impact factor: 9.623

2.  Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model.

Authors:  Adam D Kennedy; Juliane Bubeck Wardenburg; Donald J Gardner; Daniel Long; Adeline R Whitney; Kevin R Braughton; Olaf Schneewind; Frank R DeLeo
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

Review 3.  Prevention of Recurrent Staphylococcal Skin Infections.

Authors:  C Buddy Creech; Duha N Al-Zubeidi; Stephanie A Fritz
Journal:  Infect Dis Clin North Am       Date:  2015-09       Impact factor: 5.982

Review 4.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

5.  Neuroscience: Bacteria get on your nerves.

Authors:  Victor Nizet; Tony Yaksh
Journal:  Nature       Date:  2013-08-21       Impact factor: 49.962

Review 6.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

7.  Staphylococcus colonization of the skin and antimicrobial peptides.

Authors:  Michael Otto
Journal:  Expert Rev Dermatol       Date:  2010-04

8.  Pathogenicity of Bacteria Contaminating Blood Products.

Authors:  Sören G Gatermann
Journal:  Transfus Med Hemother       Date:  2011-07-12       Impact factor: 3.747

9.  Epicutaneous model of community-acquired Staphylococcus aureus skin infections.

Authors:  Ranjani Prabhakara; Oded Foreman; Roberto De Pascalis; Gloria M Lee; Roger D Plaut; Stanley Y Kim; Scott Stibitz; Karen L Elkins; Tod J Merkel
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

10.  Surface Glycopolymers Are Crucial for In Vitro Anti-Wall Teichoic Acid IgG-Mediated Complement Activation and Opsonophagocytosis of Staphylococcus aureus.

Authors:  Jong-Ho Lee; Na-Hyang Kim; Volker Winstel; Kenji Kurokawa; Jesper Larsen; Jang-Hyun An; Adnan Khan; Min-Young Seong; Min Ja Lee; Paal Skytt Andersen; Andreas Peschel; Bok Luel Lee
Journal:  Infect Immun       Date:  2015-08-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.